| 产品名称: | Streptomyces avermitilis (ex Burg et al.) Kim and Goodfellow |
|---|---|
| 商品货号: | TS193653 |
| Deposited As: | Streptomyces avermitilis |
| Strain Designations: | MA6941 |
| Isolation: | Derived from existing strain |
| Biosafety Level: | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format: | freeze-dried |
| Disclosure: | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Preceptrol®: | no |
| Type Strain: | no |
| Comments: | Glycosylation of avermectin |
| Medium: | ATCC® Medium 196: Yeast malt extract agar |
| Growth Conditions: | Temperature: 28.0°C |
| Name of Depositor: | Merck & Co., Inc. |
| U.S. Patent Number: | |
| References: | MacNeil DJ, MacNeil T. Strain of Streptomyces avermitilis capable of glycosylating avermectin compounds at the 13-and 14A positions. US Patent 5,312,753 dated May 17 1994 derived from strain MA4680 |